Vascular access type and prognosis in elderly hemodialysis patients: a propensity-score-matched study

Ru-Xin Liu1, Shuai Lin1, Li Liu1

  • 1Department of Nephrology, Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan, China.

Renal Failure
|August 9, 2024
PubMed

Insights

For elderly hemodialysis patients, arteriovenous fistulas (AVFs) show lower risks of major adverse cardiovascular and cerebrovascular events (MACCEs), hospitalization, and infection compared to tunneled cuffed catheters (TCCs). All-cause mortality did not significantly differ between AVF and TCC groups.

Area of Science:

  • Nephrology
  • Vascular Access
  • Geriatric Medicine

Background:

  • Elderly hemodialysis (HD) patients often have unique vascular access needs.
  • Tunneled cuffed catheters (TCCs) and arteriovenous fistulas (AVFs) are common vascular access methods.
  • Comparing outcomes between TCCs and AVFs in elderly HD patients is crucial for optimizing care.

Purpose of the Study:

  • To compare the impact of TCCs versus AVFs on key clinical outcomes in elderly HD patients.
  • To evaluate differences in mortality, MACCEs, hospitalization, and infection rates.
  • To identify risk factors for mortality in this population.

Main Methods:

  • Retrospective matched cohort study using propensity score matching (PSM).
  • Comparison of all-cause mortality, MACCEs, hospitalization, and infection rates.
  • Cox survival analysis for risk factor identification in patients ≥70 years old.

Main Results:

  • No significant difference in all-cause mortality between TCC and AVF groups (30.1/100 vs. 33.3/100 patient-years).
  • AVF group showed significantly lower rates of MACCEs, hospitalization, and infection compared to the TCC group.
  • High Charlson Comorbidity Index (CCI) score identified as a risk factor for death.

Conclusions:

  • AVFs are associated with reduced risks of MACCEs, hospitalization, and infection in elderly HD patients compared to TCCs.
  • No significant difference in all-cause mortality was observed between AVF and TCC vascular access.
  • Vascular access choice impacts morbidity but not overall mortality in elderly HD patients.
Abstract